Lipoglycopeptides [CS] - M000640741

Pharmacologic Class Information

Pharmacologic Code M000640741
Pharmacologic Name Lipoglycopeptides
Pharmacologic Uses
  • lipoglycopeptide antibacterial
Pharmacologic Concept Chemical Structure - [CS]
Pharmacologic Concept Description This concept refers to the chemical structure and classification containing chemicals or other drug ingredients, organized into a chemical structure classification hierarchy.

NDC Products with Lipoglycopeptides

The table contains 3 products whose active ingredient are classified under the same pharmacologic class Lipoglycopeptides [CS].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
57970-100Dalvance Non-Proprietary Name: DalbavancinInjection, Powder, For SolutionIntravenousAllergan, Inc.ACTIVE
70842-140Orbactiv Non-Proprietary Name: OritavancinInjection, Powder, Lyophilized, For SolutionIntravenousMelinta Therapeutics, LlcACTIVE
70842-225Kimyrsa Non-Proprietary Name: Oritavancin DiphosphateInjection, Powder, Lyophilized, For SolutionIntravenousMelinta Therapeutics, LlcACTIVE